Intent To Grant an Exclusion License to RSI Industries

Riepilogo

In compliance with 37 CFR 404 et seq., the Department of the Army hereby gives notice of its intent to grant to RSI Industries and Pharmaceuticals, Inc., a corporation having its principal place of business at 5051 Edison Avenue, P.O. Box 1168, Chino, CA 91708, an exclusive license under U.S. Patent Number 5,714,515, issued February 3, 1998. This Patent relates to a food product for and a method for enhancing cellular phosphorylation potential.